Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
13.42
-0.02 (-0.15%)
At close: Aug 13, 2025, 4:00 PM
13.49
+0.07 (0.52%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Paramount Global Market Cap
RGC has a market cap or net worth of $6.64 billion as of August 13, 2025. Its market cap has increased by 4,049.39% in one year.
Market Cap
6.64B
Enterprise Value
6.63B
1-Year Change
4,049.39%
Ranking
Category
Stock Price
$13.42
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $6.64B, an increase of 5,425.43%. That is a compound annual growth rate of 167.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 6.65B | 10,238.46% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
| Jul 16, 2021 | 120.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |